Follow-up of Patients with Hyperlipidemia in Policlinic

Basit Öğe Kaydı
dc.contributor.authorTatli, Ersan
dc.date.accessioned2024-06-12T11:03:35Z
dc.date.available2024-06-12T11:03:35Z
dc.date.issued2010
dc.departmentTrakya Üniversitesien_US
dc.description.abstractCoronary heart disease is the leading cause of morbidity and mortality in Turkey and one of the most predictive risk factors of coronary disease in Turkish population is the ratio of total/HDL cholesterol. Therefore, adequate treatment of dyslipidemia, particularly with statins is very important with regard to prevention of coronary heart disease. However, lipid-lowering therapy is implemented suboptimally in Turkey. There is much to do for both patients and physicians.en_US
dc.identifier.endpage41en_US
dc.identifier.issn1301-3149
dc.identifier.startpage39en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21700
dc.identifier.volume27en_US
dc.identifier.wosWOS:000289660300009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherAves Yayincilik, Ibrahim Karaen_US
dc.relation.ispartofTrakya Universitesi Tip Fakultesi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHyperlipidemiaen_US
dc.subjectGuidelinesen_US
dc.subjectTreatmenten_US
dc.titleFollow-up of Patients with Hyperlipidemia in Policlinicen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Trakya Üniversitesi Tıp Fakültesi Dergisi